Ototoxicity
From WikiMD's WELLNESSPEDIA
| Ototoxicity | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hearing loss, tinnitus, dizziness, balance disorders |
| Complications | Permanent hearing loss, vestibular dysfunction |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | Medications, chemicals, infections |
| Risks | High doses of aminoglycosides, chemotherapy agents, loop diuretics |
| Diagnosis | Audiometry, vestibular testing |
| Differential diagnosis | Presbycusis, Meniere's disease, acoustic neuroma |
| Prevention | Monitoring drug levels, using alternative medications |
| Treatment | Discontinuation of the offending agent, hearing aids, cochlear implants |
| Medication | N/A |
| Prognosis | Variable, depending on the extent of damage |
| Frequency | |
| Deaths | N/A |
Ototoxicity refers to the property of being toxic to the ear (oto-), specifically the cochlea or auditory nerve and sometimes the vestibular system; it is commonly medication-induced. Ototoxicity can result in temporary or permanent disturbances in hearing, balance, or both.
Causes[edit]
Ototoxicity is often caused by certain medications and chemicals that damage the inner ear. Common ototoxic drugs include:
- Aminoglycoside antibiotics (e.g., gentamicin, amikacin)
- Chemotherapy agents (e.g., cisplatin, carboplatin)
- Loop diuretics (e.g., furosemide, bumetanide)
- Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., aspirin, ibuprofen)
Symptoms[edit]
The symptoms of ototoxicity can vary depending on the affected part of the ear. Common symptoms include:
- Tinnitus (ringing in the ears)
- Hearing loss
- Vertigo (a sensation of spinning)
- Balance disorders
Diagnosis[edit]
Diagnosis of ototoxicity typically involves:
- Audiometry to assess hearing function
- Vestibular testing to evaluate balance function
- Detailed patient history to identify potential ototoxic agents
Prevention and Management[edit]
Preventing ototoxicity involves careful monitoring of drug levels and minimizing exposure to known ototoxic agents. Management strategies include:
- Discontinuation or substitution of the ototoxic drug
- Use of protective agents (e.g., amifostine for cisplatin-induced ototoxicity)
- Rehabilitation therapies such as hearing aids or cochlear implants for hearing loss